Psychiatry and Neurology, Neurology · Detroit, MI
NPI
1427171677
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2799 W Grand Blvd, K11
Detroit, MI, 48202
Phone (313) 916-7207
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
324 services
Medicare patients, 2024
171
Average age 64
Drug cost, 2024
$8.1M
3,754 prescriptions
Company payments, 2025
$167
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mirela Cerghet was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 96 times for 80 patients. In total Mirela Cerghet billed 324 services in 20 codes, and Medicare paid $20K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 96 | 80 | $11.92 | $1,144 |
| 99214 Office E&M - Established | Facility | 56 | 53 | $61.03 | $3,417 |
| 99215 Office E&M - Established | Facility | 48 | 41 | $98.99 | $4,752 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $138.65 | $2,218 |
| 99285 Emergency Department E&M | Facility | 15 | 15 | $142.98 | $2,145 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 12 | $11.12 | $145 |
| 99214 Office E&M - Established | Office | 13 | 12 | $77.29 | $1,005 |
| 99205 Office E&M - New | Facility | 12 | 12 | $137.89 | $1,655 |
By year: 2022 $19K for 219 services; 2023 $19K for 835 services; 2024 $20K for 324 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mirela Cerghet prescribed most often to Medicare patients was Gabapentin, with 410 prescriptions and refills. In total Mirela Cerghet wrote 3,754 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 410 | 557 | 82 | $6,961 |
| Glatiramer Acetate Generic | 405 | 416 | 50 | $989K |
| Baclofen Generic | 331 | 638 | 87 | $9,510 |
| Dimethyl Fumarate Generic | 317 | 318 | 39 | $295K |
| Kesimpta Pen Ofatumumab | 194 | 194 | 23 | $1.8M |
| Copaxone Glatiramer Acetate | 193 | 200 | 23 | $1.2M |
| Modafinil Generic | 148 | 171 | 21 | $3,408 |
| Tizanidine Hcl Generic | 139 | 239 | 38 | $2,216 |
| Dalfampridine Er Dalfampridine | 129 | 145 | 18 | $43K |
| Teriflunomide Generic | 89 | 89 | Under 11 | $116K |
| Vumerity Diroximel Fumarate | 69 | 69 | Under 11 | $544K |
| Levetiracetam Generic | 65 | 125 | 14 | $1,846 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 61 | 67 | Under 11 | $521K |
| Tecfidera Dimethyl Fumarate | 60 | 60 | Under 11 | $536K |
| Glatopa Glatiramer Acetate | 59 | 59 | Under 11 | $143K |
Brand drugs: - claims; generic drugs: 2,936 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mirela Cerghet $167 ($167 in general payments such as food, travel and fees) from 6 companies. The largest payer was EMD Serono, Inc. with $167.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 3 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.